Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACE | P12821 | 6/20 | 0.58 |
| ▸ | REN | P00797 | 4/20 | 0.58 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.58 |
| ▸ | F2 | P00734 | 1/20 | 0.58 |
| ▸ | LMNA | P02545 | 1/20 | 0.58 |
| ▸ | LTA4H | P09960 | 1/20 | 0.58 |
| ▸ | MAPT | P10636 | 1/20 | 0.58 |
| ▸ | PEPD | P12955 | 1/20 | 0.58 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.58 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.58 |
| ▸ | HTR2A | P28223 | 1/20 | 0.58 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.58 |
| ▸ | HRH1 | P35367 | 1/20 | 0.58 |
| ▸ | THPO | P40225 | 1/20 | 0.58 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.58 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.58 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.58 |
| ▸ | DPP4 | P27487 | 3/20 | 0.53 |
| ▸ | FAP | Q12884 | 2/20 | 0.53 |
| ▸ | DPP7 | Q9UHL4 | 2/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4939337 | 1.00 | ACE (0.58) | ACERENKDM4EF2LMNA | |
| SCHEMBL9439065 | 0.98 | ACE (0.56) | ACERENKDM4EF2LMNA | |
| SCHEMBL9439063 | 0.98 | ACE (0.56) | ACERENKDM4EF2LMNA | |
| SCHEMBL152403 | 0.95 | ACE (0.64) | ACERENKDM4EF2LMNA | |
| SCHEMBL593691 | 0.95 | ACE (0.64) | ACERENKDM4EF2LMNA | |
| SCHEMBL2115244 | 0.95 | ACE (0.64) | ACERENKDM4EF2LMNA | |
| SCHEMBL2115246 | 0.95 | ACE (0.64) | ACERENKDM4EF2LMNA | |
| SCHEMBL8316371 | 0.95 | ACE (0.64) | ACERENKDM4EF2LMNA | |
| SCHEMBL9164453 | 0.95 | ACE (0.64) | ACERENKDM4EF2LMNA | |
| SCHEMBL7271951 | 0.95 | ACE (0.64) | ACERENKDM4EF2LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080081823-A1 | PIPECOLIC ACID-CONTAINING ANTIDIABETIC COMPOSITIONS | AJINOMOTO CO., INC. (JP) | 2008-04-03 | — | — | US | disclosed |
| EP-1839661-A2 | Pipecolic acid-containing antidiabetic compositions | AJINOMOTO CO., INC. (JP) | 2007-10-03 | — | — | EP | disclosed |
| CN-101045055-A | Pipecolic acid-containing antidiabetic compositions | AJINOMOTO KK (JP) | 2007-10-03 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080081823-A1 | PIPECOLIC ACID-CONTAINING ANTIDIABETIC COMPOSITIONS | GPR119, PIP5K1C, PIP4K2C | ACE 3735/4885REN 1201/4885KDM4E 3520/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.